ClinicalTrials.Veeva

Menu

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining

Alcon logo

Alcon

Status

Completed

Conditions

Corneal Staining

Treatments

Device: Opti-Free RepleniSH
Device: Balafilcon A
Device: ReNu MultiPlus
Other: Unisol 4

Study type

Interventional

Funder types

Industry

Identifiers

NCT01100424
SMA-09-20

Details and patient eligibility

About

The purpose of this study was to investigate the association of inflammatory mediators found in the tear film during the development and following the induction of contact lens solution-induced corneal staining.

Enrollment

60 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For non-lens wearers:

  • Normal eyes.
  • Currently not wearing contact lenses and has not worn contact lenses for the previous 6 months.
  • Free of dry eye using the Ocular Surface Disease Index (Schiffman et al).
  • Other protocol-defined inclusion criteria may apply.

For contact lens wearers:

  • Currently wearing soft contact lenses.
  • Free of dry eye during lens wear using the Contact Lens Dry Eye Questionnaire Short-Form (Nichols et al, Cornea, 2002).
  • Reports a contact lens wearing time of at least 12 hours per day, 7 days per week, daily wear basis (not overnight wear).
  • Reports only occasional use of contact lens rewetting drops or artificial tears.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

For non-lens wearers and contact lens wearers:

  • Pregnant.
  • Participating in another research study.
  • Exhibiting staining with fluorescein in more than 5% of the total cornea (graded by "extent" of staining across 5 regions).
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

60 participants in 2 patient groups

Contact lens wearers
Experimental group
Description:
Contact lens wearers experienced three currently available contact lens/contact lens care combinations in randomized order: balafilcon A + Optifree RepleniSH, balafilcon A + ReNu MultiPlus, and balafilcon A + Unisol 4 saline.
Treatment:
Other: Unisol 4
Device: Opti-Free RepleniSH
Device: ReNu MultiPlus
Device: Balafilcon A
Non-lens wearers
No Intervention group
Description:
Non-lens wearers completed one study visit and served as the control group.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems